Concepedia

Insulin Switching

Insulin Switching is a clinical intervention strategy within diabetes management that involves the systematic transition of a patient from one type, formulation, or regimen of exogenous insulin to another, with the intent of optimizing glycemic control, minimizing adverse effects, or adapting to changing physiological needs.

86

Publications

2.6K

Citations

644

Authors

262

Institutions

Publications per year

2017–2026

27

Parents

Publications

86

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers

Sasson Nakar, Gila Yitzhaki, Reena Rosenberg et al. · Journal of Diabetes and its Complications · 2007 · 160 citations

, , +13

Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial

Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S. Bajaj et al. · The Lancet · 2023 · 135 citations

, , +13

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Athena Philis‐Tsimikas, Marisse Asong, Edward Franek et al. · The Lancet Diabetes & Endocrinology · 2023 · 131 citations

, , +15

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

Harpreet S. Bajaj, Richard M. Bergenstal, Andreas Christoffersen et al. · Diabetes Care · 2021 · 124 citations · Full text

, , +17

Optimal<tex>$H^infty$</tex>Insulin Injection Control for Blood Glucose Regulation in Diabetic Patients

F. Chee, Tyrone Fernando, Saeid Nahavandi · IEEE Transactions on Biomedical Engineering · 2005 · 101 citations

, , +16

1–5 of 86

Authors

644

  1. HW
    Hirotaka Watada

    Juntendo University, Japan

    4 publications · 168 citations

    4

    h-index

  2. WW
    Wenhui Wei

    Sanofi (United States), United States

    4 publications · 91 citations

    4

    h-index

  3. RT
    Roberto Trevisan

    University of Padua, Italy

    3 publications · 187 citations

    3

    h-index

  4. JR
    Julio Rosenstock

    Dallas Diabetes Research Center, United States

    3 publications · 390 citations

    3

    h-index

  5. RM
    Raymond Miao

    Sanofi (United States), United States

    3 publications · 50 citations

    3

    h-index

1–5 of 644

Institutions

262

  1. Novo Nordisk (Denmark)

    Copenhagen, Denmark

    14 h-index

    34 publications

    1.7K citations

  2. Sanofi (United States)

    Bridgewater, United States

    7 h-index

    21 publications

    629 citations

  3. Sanofi (France)

    Paris, France

    5 h-index

    10 publications

    376 citations

  4. University of Padua

    Padua, Italy

    5 h-index

    6 publications

    142 citations

  5. Juntendo University

    Tokyo, Japan

    5 h-index

    28 publications

    470 citations

  6. Aarhus University Hospital

    Aarhus, Denmark

    4 h-index

    4 publications

    104 citations

  7. University of Michigan

    Ann Arbor, United States

    4 h-index

    4 publications

    91 citations

  8. STATinMED (United States)

    Ann Arbor, United States

    4 h-index

    8 publications

    182 citations

1–8 of 262

Venues

  1. Diabetes Therapy

    8 publications · 149 citations

    8

    h-index

  2. Diabetes Obesity and Metabolism

    7 publications · 235 citations

    7

    h-index

  3. Diabetes Technology & Therapeutics

    5 publications · 126 citations

    5

    h-index

  4. Advances in Therapy

    4 publications · 108 citations

    4

    h-index

  5. Endocrine Journal

    3 publications · 53 citations

    3

    h-index

1–5